BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30500825)

  • 1. De novo mutations in the GTP/GDP-binding region of RALA, a RAS-like small GTPase, cause intellectual disability and developmental delay.
    Hiatt SM; Neu MB; Ramaker RC; Hardigan AA; Prokop JW; Hancarova M; Prchalova D; Havlovicova M; Prchal J; Stranecky V; Yim DKC; Powis Z; Keren B; Nava C; Mignot C; Rio M; Revah-Politi A; Hemati P; Stong N; Iglesias AD; Suchy SF; Willaert R; Wentzensen IM; Wheeler PG; Brick L; Kozenko M; Hurst ACE; Wheless JW; Lacassie Y; Myers RM; Barsh GS; Sedlacek Z; Cooper GM
    PLoS Genet; 2018 Nov; 14(11):e1007671. PubMed ID: 30500825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of GTP-binding state in RalA through Ca2+ and calmodulin.
    Park JB
    Exp Mol Med; 2001 Mar; 33(1):54-8. PubMed ID: 11322487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype.
    Lamers IJC; Reijnders MRF; Venselaar H; Kraus A; ; Jansen S; de Vries BBA; Houge G; Gradek GA; Seo J; Choi M; Chae JH; van der Burgt I; Pfundt R; Letteboer SJF; van Beersum SEC; Dusseljee S; Brunner HG; Doherty D; Kleefstra T; Roepman R
    Am J Hum Genet; 2017 Nov; 101(5):824-832. PubMed ID: 29106825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR resonance assignments for the active and inactive conformations of the small G protein RalA.
    Shafiq A; Campbell LJ; Owen D; Mott HR
    Biomol NMR Assign; 2020 Apr; 14(1):87-91. PubMed ID: 31916136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.
    Neyraud V; Aushev VN; Hatzoglou A; Meunier B; Cascone I; Camonis J
    J Biol Chem; 2012 Aug; 287(35):29397-405. PubMed ID: 22700969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural study of the Cdc25 domain from Ral-specific guanine-nucleotide exchange factor RalGPS1a.
    Peng W; Xu J; Guan X; Sun Y; Zhang XC; Li X; Rao Z
    Protein Cell; 2011 Apr; 2(4):308-19. PubMed ID: 21494904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Ral-GppNHp and Ral-GDP reveal two binding sites that are also present in Ras and Rap.
    Nicely NI; Kosak J; de Serrano V; Mattos C
    Structure; 2004 Nov; 12(11):2025-36. PubMed ID: 15530367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.
    Takaya A; Ohba Y; Kurokawa K; Matsuda M
    Mol Biol Cell; 2004 Jun; 15(6):2549-57. PubMed ID: 15034142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
    Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
    Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding.
    Fenwick RB; Prasannan S; Campbell LJ; Nietlispach D; Evetts KA; Camonis J; Mott HR; Owen D
    Biochemistry; 2009 Mar; 48(10):2192-206. PubMed ID: 19166349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human platelet GTPase activating protein for the Ral GTP-binding protein.
    Bhullar RP; Seneviratne HD
    Biochim Biophys Acta; 1996 May; 1311(3):181-8. PubMed ID: 8664345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis for the transition from Ras-GTP to Ras-GDP.
    Hall BE; Bar-Sagi D; Nassar N
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12138-42. PubMed ID: 12213964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
    Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
    Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic variants in FBXL3 cause intellectual disability, delayed motor development and short stature.
    Ansar M; Paracha SA; Serretti A; Sarwar MT; Khan J; Ranza E; Falconnet E; Iwaszkiewicz J; Shah SF; Qaisar AA; Santoni FA; Zoete V; Megarbane A; Ahmed J; Colombo R; Makrythanasis P; Antonarakis SE
    Hum Mol Genet; 2019 Mar; 28(6):972-979. PubMed ID: 30481285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanosine triphosphatase stimulation of oncogenic Ras mutants.
    Ahmadian MR; Zor T; Vogt D; Kabsch W; Selinger Z; Wittinghofer A; Scheffzek K
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7065-70. PubMed ID: 10359839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant HRAS transcript processing underlies a distinctive phenotype within the RASopathy clinical spectrum.
    Pantaleoni F; Lev D; Cirstea IC; Motta M; Lepri FR; Bottero L; Cecchetti S; Linger I; Paolacci S; Flex E; Novelli A; Carè A; Ahmadian MR; Stellacci E; Tartaglia M
    Hum Mutat; 2017 Jul; 38(7):798-804. PubMed ID: 28390077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
    Guin S; Theodorescu D
    Acta Pharmacol Sin; 2015 Mar; 36(3):291-7. PubMed ID: 25557115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
    Tong LA; de Vos AM; Milburn MV; Kim SH
    J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.